Latest News for BIOVF
STOCKHOLM, March 27, 2026 /PRNewswire/ -- The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting (the "Meeting"), to be held on Wednesday, 6 May 2026 at 10.00 at IVA Konferenscenter, Grev Turegatan 16, Stockholm, Sweden.
Swedish Orphan Biovitrum AB (publ) (SWOBY) Analyst/Investor Day Transcript
Swedish Orphan Biovitrum AB (publ) (SWOBY) Q4 2025 Earnings Call Transcript
Swedish Orphan Biovitrum (OTCMKTS:BIOVF - Get Free Report) and Astria Therapeutics (NASDAQ: ATXS - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations. Valuation and Earnings This table compares Swedish
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for BIOVF.
Senate Trading
No Senate trades found for BIOVF.
U.S. House Trading
No House trades found for BIOVF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.